7 companies to watch during Q2 earnings

2018 is already half over, but expect fireworks now that President Trump has turned his attention to seeking lower drug prices. The Tweeter-in-Chief publicly shamed companies that have tried to take the typical mid-year price increases. 

Without the usual bump in price, some companies are going to face stagnate growth to some of their biggest products. The upcoming second quarter earnings calls promise to offer insights from executives making their stance on the topic known.